CureVac NV (CureVac NV) Days Payable : 49.94 (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is CureVac NV Days Payable?

CureVac NV's average Accounts Payable for the three months ended in Dec. 2023 was $31.99 Mil. CureVac NV's Cost of Goods Sold for the three months ended in Dec. 2023 was $58.45 Mil. Hence, CureVac NV's Days Payable for the three months ended in Dec. 2023 was 49.94.

The historical rank and industry rank for CureVac NV's Days Payable or its related term are showing as below:

CVAC' s Days Payable Range Over the Past 10 Years
Min: 90.58 Med: 175.53 Max: 289.62
Current: 90.58

During the past 6 years, CureVac NV's highest Days Payable was 289.62. The lowest was 90.58. And the median was 175.53.

CVAC's Days Payable is ranked worse than
61.06% of 719 companies
in the Biotechnology industry
Industry Median: 147.29 vs CVAC: 90.58

CureVac NV's Days Payable declined from Dec. 2022 (66.96) to Dec. 2023 (49.94). It may suggest that CureVac NV accelerated paying its suppliers.

CureVac NV Days Payable Historical Data

The historical data trend for CureVac NV's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CureVac NV Days Payable Chart

CureVac NV Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

95.06

289.62

108.21

197.05

165.32

CureVac NV Quarterly Data
	Dec18	Mar19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Payable	Get a 7-Day Free Trial															66.96	182.40	49.79	49.22	49.94

Competitive Comparison of CureVac NV's Days Payable

For the Biotechnology subindustry, CureVac NV's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CureVac NV's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CureVac NV's Days Payable distribution charts can be found below:

* The bar in red indicates where CureVac NV's Days Payable falls into.

CureVac NV Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

CureVac NV's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (72.294	+	50.562)	/	2 )	/	135.623	*	365
=	61.428					/	135.623	*	365
=	165.32

CureVac NV's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (13.415	+	50.562)	/	2 )	/	58.449	*	365 / 4
=	31.9885					/	58.449	*	365 / 4
=	49.94

CureVac NV Days Payable Related Terms

Thank you for viewing the detailed overview of CureVac NV's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

CureVac NV (CureVac NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CureVac NV (NAS:CVAC) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

CVAC:Mexico 1CVAC:Italy 0A9E:UK 5CV:Germany CVAC:Austria

Address

Friedrich-Miescher-Strasse 15, Tubingen, BW, DEU, 72076

Website

https://www.curevac.com

CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid (mRNA). The company was founded in 2000 and had its initial public offering in August 2020. CureVac is collaborating with GlaxoSmithKline to develop a second-generation COVID-19 vaccine. CureVac's first attempt to develop a COVID-19 vaccine did not have sufficient efficacy data, and its trials were discontinued in October 2021. The company's other pipeline candidates include mRNA vaccines for influenza, rabies, and malaria. Additionally, CureVac is in the early stages of development for oncology and molecular therapies spanning tumors, liver, ocular, and lung diseases.